Related Experiment Video

Updated: Jul 25, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Assessment of a new home-based care pathway for children newly diagnosed with type 1 diabetes

Laetitia Gauche1, Rémi Laporte2, Delphine Bernoux1

  • 1Multidisciplinary Pediatrics Department, Timone Enfants Hospital, APHM, Marseille, France.

Primary Care Diabetes
|June 30, 2023
PubMed

Insights

Home-based care for children with type 1 diabetes mellitus is safe and effective, reducing hospital stays. This approach ensures comparable glycemic control and quality of care, particularly benefiting socioeconomically deprived families.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1DM) diagnosis in children requires comprehensive care management.
  • Traditional hospital-based care involves extended inpatient stays, potentially impacting families and resource utilization.

Purpose of the Study:

  • To compare the efficacy and outcomes of home-based versus conventional hospital-based care for newly diagnosed pediatric T1DM patients.
  • To evaluate the impact of home-based care on hospital stay duration, glycemic control, family knowledge, and quality of life.

Main Methods:

  • A descriptive study included 85 children newly diagnosed with T1DM between November 2017 and July 2019.
  • Patients were allocated to either home-based care or in-patient hospital care.
  • Outcomes assessed included initial hospital stay length, first-year glycemic control, family diabetes knowledge, and quality of life.

Main Results:

  • The home-based care group had a shorter initial hospital stay (6 days) compared to the in-patient group (9 days).
  • Glycemic control, diabetes knowledge, and overall quality of care were comparable between the two groups.
  • The home-based care group included a higher proportion of socioeconomically deprived families.

Conclusions:

  • Home-based care is a safe and effective alternative for managing newly diagnosed pediatric T1DM.
  • This innovative healthcare model offers significant social care benefits, especially for vulnerable, socioeconomically disadvantaged families.
Abstract

Keywords:
DeprivationDiabetesHome-based carePediatric

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

4.1K

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
603
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213